SCNI

Scinai Immunotherapeutics
SCNI

6 hedge funds and large institutions have $60.9K invested in Scinai Immunotherapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

66% less capital invested

Capital invested by funds: $181K → $60.9K (-$120K)

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$21.5K
2
+$18.6K
3
+$1.26K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$88

Top Sellers

1
-$95.8K
2
-$22.9K
3
-$15.1K
4
Morgan Stanley
Morgan Stanley
New York
-$13
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$36.2K
TSS
2
Two Sigma Securities
New York
$18.6K
RhumbLine Advisers
3
RhumbLine Advisers
Massachusetts
$4.49K
Northwestern Mutual Wealth Management
4
Northwestern Mutual Wealth Management
Wisconsin
$1.26K
Morgan Stanley
5
Morgan Stanley
New York
$310
UBS Group
6
UBS Group
Switzerland
$10
YAG
7
Yorkville Advisors Global
New Jersey
–
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
–